Pharmaceutical Technology

JUNE 19, 2025

GlobalData Healthcare June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The oligonucleotide market is well-positioned to drive the next wave of personalised treatment. billion from 2021 to 2025 year-to-date. Credit: Kateryna Kon via Shutterstock. ASOs accounted for more than half ($3.54

Communication 52

Communication Hospitals Pharmaceutical Manufacturing Packaging 52

PharmaState Academy

DECEMBER 18, 2024

This quiz competition is brought to you by Now & Next Summit on Pharma Marketing | Edition 2 scheduled for 18th Jan 2025 at Jio World Convention Centre, BKC, Mumbai. a) 60% b) 80% c) 40% d) 30% 6 / 20 What is the impact of personalized scientific communication on HCPs? How to Participate?

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Marketing Network

OCTOBER 17, 2024

As we approach 2025, the pharmaceutical industry is witnessing a seismic shift in marketing strategies, driven by technological advancements and evolving consumer expectations. With the increasing digitization of healthcare, pharmaceutical companies are leveraging digital platforms to reach broader audiences more effectively.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Scheduling Appointments 52

Pharma Marketing Network

JANUARY 7, 2025

In 2025, pharma marketing news is filled with innovation, disruption, and opportunities to grow your business. Digital Dominance in Pharma Marketing The digital revolution has officially taken over the pharmaceutical industry, and theres no turning back. A significant focus for regulatory bodies has been on transparency.

HIPAA 52

HIPAA Communication Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JUNE 25, 2025

Abigail Beaney June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The EHDS has come into force but it has not yet been fully rolled out, with EU member states still in discussions over how the legislation will work. One of the two panels on EHDS at HLTH Europe 2025. Image credit: Abigail Beaney / GlobalData.

Communication 52

Communication Hospitals Packaging Pharmaceutical Companies 52

Pharmaceutical Technology

JUNE 6, 2025

Robert Barrie June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook US health secretary Robert F Kennedy Jr. In one of the fierier remarks from the roundtable, RFK Jr said: “At every level, doctors, other providers, our hospitals, the pharmaceutical companies, the insurance companies, all make money by keeping us sick.

Insurance Coverage and Processing 81

Insurance Coverage and Processing Communication Hospitals Drug Development 81

Pharmaceutical Technology

JUNE 25, 2025

GlobalData Healthcare June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The future Alzheimer’s disease treatment paradigm is anticipated to be combinatorial. The momentum in acquisition activity continued into 2025, with total deal value reaching $16.8 Credit: JLStock via Shutterstock.

Packaging 59

Packaging Biosimilars Communication Hospitals 59

Pharma Marketing Network

MAY 23, 2025

In 2025, artificial intelligence is helping pharmaceutical brands bridge the gap between regulatory precision and meaningful engagement. In 2025, AI is helping medical affairs teams streamline global content review by auto-tagging references, linking claims to citations, and maintaining audit trails.

Documentation 64

Documentation Communication Pharmaceutical Companies Pharmaceutical Companies 64

Pharma Marketing Network

DECEMBER 17, 2021

The wave of interest in sustainability follows the value chain from top-tier pharmaceutical companies to their suppliers of every size. About 80% of pharmaceutical companies have announced a commitment to becoming carbon-neutral or made a net-zero pledge for carbon emissions. Health for Humanity 2025 Goals.

Pharmaceutical Companies 103

Pharmaceutical Companies Pharmaceutical Companies Communication 103

Pharma Marketing Network

APRIL 3, 2025

This article dives deep into how patient marketing has changed, whats driving this transformation, and what strategies are leading the way for 2025 and beyond. The Digital Transformation of Patient Marketing Technology has revolutionized how pharma communicates with patients. FAQs What is patient marketing in pharma?

HIPAA 52

HIPAA Communication Packaging Pharmaceutical Companies 52

Viseven

JUNE 18, 2025

Scientific communication : Drafting slide decks, scientific responses, medical information letters, and training content using generative models, ensuring scientific accuracy and compliance in messaging and content. Previously, many organizations, including healthcare companies and facilities, were merely testing the waters.

Labelling 52

Labelling Communication Drug Development Documentation 52

Pharma Marketing Network

MAY 2, 2025

For pharmaceutical companies, this means that branding can no longer rely solely on clinical data or catchy taglines. Healthcare professionals (HCPs), too, are inundated with branded communications. Patient-Centric Communication Todays healthcare audience expects to be spoken tonot talked at.

Communication 52

Communication Customer Service Labelling Pharmaceutical Companies 52

Viseven

AUGUST 29, 2024

Although 5G is currently limited to large cities in developed countries, by around 2025, we can expect its reach will extend beyond the urban areas. As this trend unfolds, it is vital to understand the benefits 5G brings, how it impacts healthcare communication , and how healthcare businesses can leverage it. What Is 5G?

Communication 52

Communication Hospitals Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JANUARY 10, 2023

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. It flows from every direction in torrents to create huge opportunities to address the world’s mounting health issues.

Compounding 98

Compounding Communication Pharmaceutical Companies Pharmaceutical Companies 98

PharmaState Academy

DECEMBER 18, 2024

This quiz competition is brought to you by Now & Next Summit on Pharma Marketing | Edition 2 scheduled for 18th Jan 2025 at Jio World Convention Centre, BKC, Mumbai. Name Email Phone Number Company Department Designation 1 / 20 What is the primary goal of scientific communication in Pharma Marketing? How to Participate?

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

APRIL 25, 2023

A few months later, the board of the nonprofit Vaccine Alliance Gavi approved an initial investment of nearly $160 million, to be given between 2022 and 2025, to support the rollout of the malaria vaccine in GAVI-eligible countries. However, making sure the vaccine reaches everyone can be challenging due to the storage requirements.

Vaccines 69

Vaccines Communication Pharmaceutical Companies Pharmaceutical Companies 69

Pharmaceutical Technology

JUNE 19, 2023

Pharmaceutical companies are putting their trust in the immense potential this new generation of medicine has for treating individuals with rare genetic diseases, which currently affect an estimated 280 million patients worldwide.

Packaging 52

Packaging Compounding Communication Pharmaceutical Companies 52

Viseven

JANUARY 4, 2023

From life-saving drugs discovery, development, and production to clinical trials, communication, and drug target identification — AI pharmaceutical is a definite game-changer. The post The Use of Artificial Intelligence in the Pharmaceutical Industry appeared first on Viseven.

Drug Development 52

Drug Development Medical Records Communication Pharmaceutical Companies 52

pharmaphorum

APRIL 19, 2022

“In a situation where most of the development of treatments in Korea is mostly centred on cancer and metabolic diseases, I noticed that there weren’t any companies that were focusing on sensory diseases.”. Kim says the Dry Eye Disease market is large and growing, with analysts predicting it will hit $6 billion USD by 2025.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Drug Development 52

Pharmaceutical Technology

DECEMBER 22, 2022

The new joint procedure will launch in Q1 2025 for oncology medicines and other advanced therapy medicinal products and extend to orphan drugs in 2028. By 2030, JCAs will be carried out on all medicinal products with an EMA-issued MA. Will the joint procedure drive positive change? Please check your email to download the Case Study.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Labelling Communication 52

Pharma Marketing Network

MAY 11, 2025

By 2025, the Centers for Medicare and Medicaid Services (CMS) will negotiate pricing on over 20 drugs, including top-sellers such as Eliquis , Xarelto , and Jardiance. Build Brand Equity Through Value-Based Messaging Asian pharma marketing professionals must revisit how value is communicated. exports or licensing agreements with U.S.

Drug Pricing 59

Drug Pricing Biosimilars Communication Immunity 59

pharmaphorum

OCTOBER 13, 2022

However, patent protection remains in some major markets, including France, Italy, Spain, and the UK until 2025. The question is whether other major pharmaceutical companies will be attracted to the space – particularly when areas such as oncology and orphan drugs currently provide a larger return on investment.

Biosimilars 98

Biosimilars Communication Pharmaceutical Companies Pharmaceutical Companies 98

Viseven

MAY 9, 2025

Source: [link] Demonstrating value Pharmaceutical companies are expected to go beyond simply proving that their treatments work they need to show that their products provide real, measurable benefits for both patients and healthcare systems. How Does the HEOR Model Work for Pharmaceutical Companies?

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 52

pharmaphorum

MARCH 12, 2021

Behind all of these are massive and growing volumes of data that life sciences companies generate, manage and analyse to secure breakthroughs. One estimate [1] suggests that by 2025 more than 60 million patients will have their genome sequenced. And those volumes will only increase.

Vaccines 111

Vaccines Communication Pharmaceutical Companies Pharmaceutical Companies 111

Pharmaceutical Technology

MARCH 22, 2023

Large-molecule drugs such as biologics are particularly sensitive to foreign contamination and E&L interaction, making these issues key concerns for pharmaceutical companies. From 2025, it will be substituted with a new chapter on functional tests for the complete system.” Please check your email to download the Webinar.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

APRIL 24, 2023

Meanwhile, the Indian biologics market is expected to grow to $12 billion by 2025, with a compound annual growth rate (CAGR) of 22%. As a result, some pharmaceutical companies are turning to third parties. Moreover, skilled manpower is required to run these facilities. Please check your email to download the Whitepaper.

Vaccines 52

Vaccines Compounding Communication Immunity 52

Express Pharma

MARCH 28, 2025

Suven Pharmaceuticals announced that the National Company Law Tribunal (NCLT), vide its order pronounced on March 27, 2025, has sanctioned the Scheme of Amalgamation between Cohance Lifesciences and Suven Pharmaceuticals. As previously communicated, the Company expects to complete the amalgamation process by Q1FY26.

Communication 89

Communication Pharmaceutical Companies Pharmaceutical Companies 89

STAT

APRIL 30, 2025

The cuts targeted 3,500 employees at the FDA and broadly hit staff working in program management, human resources, technology, policy, communications, and other administrative areas. Drugmakers spent a record $31 million to lobby in Washington last year, and about $13 million in the first quarter of 2025, according to public filings.

Communication 183

Communication Pharmaceutical Companies Pharmaceutical Companies 183

pharmaphorum

JUNE 17, 2025

Skip to main content Tuesday 17 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes 52

Diabetes Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 52

FDA Law Blog: Biosimilars

JUNE 1, 2025

With regard to influencers, the Federal Trade Commission (FTC) maintains its Endorsement Guides and, in 2021, sent over 700 Notice of Penalty Offenses letters, a number of which were directed toward pharmaceutical companies.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Compounding Communication 59

Pharmaceutical Technology

JUNE 25, 2025

Robert Barrie June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook RFK Jr has embarked on a mission to reset vaccine regulation and evidence generation in the US. In May 2025, he said that all new vaccines would need to be developed without using mRNA technology. Credit: Novikov Aleksey via Shutterstock.

Vaccines 115

Vaccines Hospitals Packaging Communication 115

Pharma Marketing Network

MAY 14, 2025

On May 12, 2025, President Donald Trump signed an executive order aiming to make this a reality. This move seeks to reduce prescription drug costs by up to 80%, introducing significant changes to the pharmaceutical landscape. Key components of the order include: Price Alignment: Pharmaceutical companies are required to adjust U.S.

Drug Pricing 59

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Communication 59

Pharmaceutical Technology

JUNE 10, 2025

Robert Barrie and Ross Law June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The removal ACIP members marks the most significant upheaval to the current vaccine landscape under Trump’s administration. lev radin via Shutterstock. Give your business an edge with our leading industry insights.

Vaccines 52

Vaccines Insurance Coverage and Processing Drug Pricing Immunity 52

Pharmaceutical Technology

JUNE 27, 2025

Robert Barrie June 27, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The list price for a month’s supply of 2.4mg Wegovy – the drug’s highest does – is $1,350 in the US, whereas the same dose in the UK costs £175.80 each month. “I Mochi Health is even the subject of a lawsuit initiated by Eli Lilly.

Drug Pricing 59

Drug Pricing Compounding Packaging Communication 59

Pharmaceutical Technology

JUNE 18, 2025

Leyla Hasanzadeh June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Tech transfer for manufacturing purposes in India will be difficult if Trump imposes import duties on pharmaceuticals. The next few weeks of June and July 2025 will be pivotal for their trade relationship as negotiations enter advanced stages.

Drug Pricing 52

Drug Pricing Communication Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JUNE 11, 2025

Robert Barrie June 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Drugmakers have poured billions of dollars into pharma manufacturing facilities across the US as they adapt to macroeconomic pressures. Novartis, Eli Lilly, and Genentech have also made US investment announcements in the wake of Trump’s reforms.

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Communication Hospitals Packaging 52